Psychotropic Analgesic Nitrous Oxide and Neurotransmitter Mechanisms Involved in the Alcohol Withdrawal State

References

• Abercrombie E. D., Jacobs B. L. Systemic naloxone administration potentiates locus coeruleus nor adrenergic neuronal activity under stressful but not non-stressful conditions. Brain Research 1988; 441: 362–366
   PubMed Web of Science ®Google Scholar
• Adinoff B., Risher-Flowers D., DeJong J., Ravitz B., Bone G. H. A., Nutt D. J., Roehrich L., Martin P. R., Linnoila M. Disturbances of hypothalamic-pituitary-adrenal axis functioning during ethanol withdrawal in six men. American Journal of Psychiatry 1991; 148: 1023–1025
   PubMed Web of Science ®Google Scholar
• Aghajanian G. K., Alreja M., Nestler E. J., Kogan J. H. Dual mechanisms of opiate dependence in the locus coeruleus. Clinical Neuropharmacology 1992; 15(suppl 1)143A–144A
   Google Scholar
• Banerjee S. P., Sharma V. K., Khanna J. M. Alterations in beta-adrenergic receptor binding during ethanol withdrawal. Nature 1978; 276: 407–408
   PubMed Web of Science ®Google Scholar
• Beil H., Trojan A. The use of apomorphine in the treatment of alcoholism and other addictions. British Journal of Addiction 1977; 72: 129–134
   Google Scholar
• Blum K., Elston S. F. A., DeLalo L., Briggs A. H., Wallace J. E. Ethanol acceptance as a function of genotype amounts of brain (met)enkephalin. Proceedings of National Academy of Science USA 1983; 80: 6510–6512
   PubMed Web of Science ®Google Scholar
• Borg V., Weinholdt T. Bromocriptene in the treatment of alcohol withdrawal. Acta Psychiatrica Scandinavia 1982; 65: 101–111
   PubMed Web of Science ®Google Scholar
• Blum K., Bottiglieri T. Methylation and neuropsychiatry. Baylor University Medical Center Proceedings 1992; 5: 13–25
   Google Scholar
• Briggs A. H., Wallace J. E., Hall C. W., Trachtenberg M. A. Regional brain (met)-enkephalin in alcohol preferring and non-alcohol preferring inbred strains of mice. Experientia 1987; 43: 408–410
   PubMedGoogle Scholar
• Bozarth M. A. Ventral tegmental reward system. Brain Reward Systems and Abuse, K. Jorgen, J. Engel, L. Oreland, D. H. Ingvar, B. Pernow, S. Rossner, L. A. Pellborn. Raven, New York 1987; 1–17
   Google Scholar
• Carey C., Clark A., Saner T. Analgesic nitrous oxide for addictive withdrawal states in general practice. South African Medical Journal 1991; 79: 516
   PubMed Web of Science ®Google Scholar
• Cash D. J., Subbarao K. Different effects of pentobarbital on two gamma-aminobutyrate receptors from rat brain: channel opening, desensitization and an additional conformational changes. Biochemistry 1988; 27: 4580–4590
   PubMedGoogle Scholar
• Cheramy A., Nieoullon A., Glowinski W. In vivo changes in dopamine release in cat caudate nucleus and substantia nigra induced by nigral application of various drugs including GABA-ergic agonists and antagonists. Interactions Between Putative Neurotransmitters in the Brain, S. Garattini, J. F. Pujol, R. Samanin. Raven Press, New York 1978; 175–190
   Google Scholar
• Cohen M. R., Pickar D., Dubois M. The role of the endogenous opioid system in the human stress response. Medical Clinics of North America 1983; 6: 457–471
   Google Scholar
• Collinge J., Pycock C. J., Taberner P. V. Studies of the interaction between cerebral 5-hydroxytryptamine and gamma-aminobutyric acid in the mode of action of diazepam in the rat. British Journal of Pharmacology 1983; 79: 637–643
   PubMed Web of Science ®Google Scholar
• Costa E. Some new vista on neuronal communication mechanisms. Interactions Between Putative Neurotransmitters in the Brain, S. Garattini, J. F. Pujol, R. Samanin. Raven Press, New York 1978; 75–87
   Google Scholar
• Costa E., Cheney B. L. Regulation of cholinergic neurons by dopaminergic terminals: influence of cataleptogenic and noncatoleptogenic antipsychotics. Interactions Between Putative Neurotransmitters in the Brain, S. Garattini, J. F. Pujol, R. Samanin. Raven Press., New York 1978; 23–38
   Google Scholar
• Crossland J. Neurohumoral substances and drug abstinence syndromes. Advances in Neuro-psychopharmacology, O. Vinar, Z. Votava, P. B. Bradley. North Holland Publishing Co., Amsterdam 1971; 497–507
   Google Scholar
• Daouste M., Compagnon P., Lagrande E., Mocaer E. Y., Retton M. C. Tianeptine, a specific serotonin uptake enhancer with antidepressant properties, decreases ethanol intake in rats. Clinical Neuropharmacology 1992; 15(suppl 1)207B
   Google Scholar
• Dave J. R., Eiden L. E., Karanian J. W., Eskay R. L. Ethanol exposure decreases pituitary corticotropin-releasing factor binding and adenylate cyclase activity, pro-opioimelanocortin biosynthesis and plasma Beta-endorphin levels in the rat. Endocrinology 1986; 118: 280–286
   PubMed Web of Science ®Google Scholar
• Daynes G. The initial management of alcolohism using oxygen and nitrous oxide: a transcultural study. International Journal of Neuroscience 1989; 49: 83–86
   PubMed Web of Science ®Google Scholar
• DeFeudis F. V. Central Cholinergic Systems in Behaviour. Academic Press, London 1974; 142
   Google Scholar
• Dick P., Grandjean M. E., Tissot R. Successful treatment of withdrawal symptoms with delta-sleep inducing peptide (DSIP), a neuropeptide with potential agonistic activity on opiate receptors. 13th C1NP Congress, Jerusalem, 1982; vol 1: 170, Abstracts
   Google Scholar
• Ebert T. J., Kampine J. P. Nitrous oxide augments sympathetic outflow: direct evidence from human peroneal nerve recordings. Anesthesia & Analgesia 1989; 69: 444–449
   PubMedGoogle Scholar
• Eisenhofer G., Lambie D. G., Whiteside E. A., Johnson R. H. Vasopressin concentrations during alcohol withdrawal. British Journal of Addiction 1985; 80: 195–199
   PubMedGoogle Scholar
• Engel J. A., Fahlke C., Hard E., Johannssen K., Svensson N., Soderpalm B. Serotinergic and dopaminergic involvement in ethanol intake. Clinical Neuropharmacology 1992; 15(suppl 1)64a–65a
   Google Scholar
• Febiger H. C., Phillips A. G. The role of catecholamine transmitters in brain reward systems: implications for the neurobiology of affect. Brain Reward Systems and Abuse 1987; 61–74, Ibid.
   Google Scholar
• Feldberg W. S. Fifty years on: looking back on some developments in neurohumoral physiology. Liverpool University, Liverpool 1982; 66–80
   Google Scholar
• Fisher L. A., Brown M. R. Central regulation of stress responses: regulation of the autonomic nervous system and visceral function by corticotrophin releasing factor-41. Ballieres Clinical Endocrinology and Metabolism 1991; 5: 35–50
   PubMedGoogle Scholar
• Froehlich J. C., Li T.-K. Alcoholism: a molecular perspective. Abstract presented at the NATO conference Molecular pathology of alcoholism at the NATO Advanced Study Institute, T. N. Palmer. NATO ASC Series 1991, 1991; 206: 64, August 26-September 6, 1990
   Google Scholar
• Fujimoto A., Nagao T., Ebara T., Sato M., Otsuki S. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. Biological Psychiatry 1983; 18: 1141–1152
   PubMed Web of Science ®Google Scholar
• Genazzini A. R., Nappi G., Facchinetti F., Mazzella G. L., Parrini D., Sinforiani E., Petraglia F., Savoli F. Central deficiency of beta-endorphin in alcohol addicts. Journal of Clinical Endocrinology and Metabolism 1982; 55: 583–586
   PubMedGoogle Scholar
• Gessa G. L., Gallimberti L. Gamma-hydroxybutyric acid in the treatment of alcohol dependence. Clinical Neuropharmacology 1992, suppl 1: 303A
   Google Scholar
• Gianoloukis C., Belivean D., Angelogianni P., Meanay M., Tavundayil J., Tawar V., Dumas M. Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk of future development of alcoholism. Life Sciences 1989; 45: 1097–1109
   PubMedGoogle Scholar
• Gillman M. A. Nitrous oxide as an opioid agonist: some experimental and clinical applications. DSc at Potchefstroom University for CHO, South Africa 1985, Thesis accepted in fulfillment of the requirements of
   Google Scholar
• Gillman M. A. Analgesic nitrous oxide should join the opioid family after almost two centuries. South African Journal of Science 1993; 89: 25–27
   Google Scholar
• Gillman M. A., Katzeff I. Does opioid uncoupling of adrenal responses mediate opioid anti-stress effects. Medical Science Research 1988; 16: 207–209
   Google Scholar
• Gillman M. A., Katzeff I., Vermaak W. J. H., Becker P. J., Susani E. Hormonal responses of analgesic nitrous oxide. Hormone and Metabolic Research 1988; 20: 751–754
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J. Receptor hypothesis of the alcohol withdrawal state. CNS receptors–from molecular pharmacology to behaviour, P. Mandel, F. V. DeFeudis. Raven, New York 1983; 405–415
   Google Scholar
• Gillman M. A., Lichtigfeld F. J. Minimal sedation required with nitrous oxide-oxygen treatment of the alcohol withdrawal state. British Journal of Psychiatry 1986; 148: 604–606
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J. Analgesic nitrous oxide for alcohol withdrawal: a critical appraisal after 10 years' use. Postgraduate Medical Journal 1990a; 66: 543–546
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Lichtigfeld F. J. The drug management of severe alcohol withdrawal syndromes. Postgraduate Medical Journal 1990b; 66: 1005–1009
   PubMedGoogle Scholar
• Gillman M. A., Lichtigfeld F. J. Placebo and analgesic nitrous oxide for the treatment of the alcohol withdrawal state. British Journal of Psychiatry 1991; 159: 672–675
   PubMed Web of Science ®Google Scholar
• Gillman M. A., Sandyk R. Autotolerance to the endogenous opioids and sleep. Medical Hypothesis 1985; 16: 393–395
   PubMed Web of Science ®Google Scholar
• Gold M. S., Rea W. S. The role of endorphins in opiate addiction, opiate withdrawal and recovery. Psychiatric Clinics of North America 1983; 6: 489–520
   PubMedGoogle Scholar
• Goldstein D. B. Interactions of ethanol with neurotransmitter systems. Pharmacology of Alcohol. Oxford University Press, New York 1983; 141–155
   Google Scholar
• Harper H. A., Rodwell V. W., Mayes P. A. Catabolism of amino acids. Review of Physiological Chemistry 17th Ed. Lange, California 1977; 337–368
   Google Scholar
• Harris W. C., Alpert W. J., Gill J. J., Marcinko D. E. Nitrous oxide and valium use in podiatric surgery for production of conscious-sedation. Journal of American Podiatric Association 1982; 72: 505–509
   PubMedGoogle Scholar
• Hertz A. Opioid peptides: their role in drug dependence. Addiction and Brain Damage, D. Richter. Croom Helm, London 1980; 141–149
   Google Scholar
• Hery F., Giorguieff M. F., Hamon M., Besson M. J., Glowinski J. Role of cholinergic receptors in the release of newly synthesized amines from serotinergic and dopaminergic terminals. Interactions Between Putative Neurotransmitters in the Brain, S. Garattini, J. F. Pujol, R. Samanin. Raven Press, New York 1978; 39–51
   Google Scholar
• Hoffer B. J., Freedman R., Woodward D. J., Puro D., Moises H. A functional role for adrenergic input to the cerebellar cortex: Interaction of norepinephrine with mossy and climbing fiber excitation and GABA-mediated inhibition. Interactions Between Putative Neurotransmitters in the Brain, S. Garattini, J. F. Pujol, R. Samanin. Raven, New York 1978; 231–243
   Google Scholar
• Hoffman P. L., Grant K. A., Snell L. D., Reinlib L., Iorio K., Tabakoff B. NMDA receptors: role in ethanol withdrawal seizures. Annals New York Academy of Sciences 1992; 654: 52–60
   PubMedGoogle Scholar
• Holloway M. Trends in pharmacology: Rx for addiction. Scientific American 1991; 264: 70–79
   Google Scholar
• Holman R. B., Snape B. M., Widdowson P. S. Naloxone elicits dose dependent changes in alcohol-induced increases in endogenous dopamine release from rat striatum. Alcohol & Alcoholism 1987, suppl 1: 737–741
   Google Scholar
• Hong J. S., Majchrowicz E., Hunt W. A., Gillin J. C. Reduction in cerebral methionine-enkephalin content during the ethanol withdrawal syndrome. Substance Alcohol Action/Misuse 1981; 2: 233–240
   Google Scholar
• Huang C., Liu G., Hsiao C. F., Huang R. Electrophysiology of ethanol, nitrous oxide, and barbiturates on presumed subtypes of cerebellar granule cells. Annals of the New York Academy of Sciences 1991; 625: 264–268
   PubMedGoogle Scholar
• Jaffe J. H., Martin W. R. Opioid analgesic and antagonists. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 7th Ed., A. Goodman-Gilman, L. S. Goodman, T. Rall, F. Murad. Macmillan, New York 1985; 491–531
   Google Scholar
• Jouvet M. Biogenic amines and the states of sleep. Science 1969; 163: 2–41
   Google Scholar
• Kramp P., Rafaelsen O. J. Delirium tremens: a double-blind comparison of diazepam and barbital treatment. Acta Psychiatrica Scandinavia 1978; 58: 174–190
   PubMedGoogle Scholar
• Kraus M. L., Gottlieb L. D., Horwitz R. I., Anscher M. Randomised clinical trial of atenolol in patients with alcohol withdrawal. New England Journal of Medicine 1985; 313: 905–909
   PubMed Web of Science ®Google Scholar
• Ladinsky H., Consolo S., Bianchi S., Ghezzi D., Samanin R. Link between dopaminergic and cholinergic neurons in the striatum as evidence by pharmacological, biochemical and lesion studies. In Interactions Between Putative Neurotransmitters in the Brain. Interactions Between Putative Neurotransmitters in the Brain, S. Garattini, J. F. Pujol, R. Samanin. Raven Press, New York 1978; 3–21
   Google Scholar
• Lichtigfeld F. J., Gillman M. A. The treatment of alcoholic withdrawal states with oxygen and nitrous oxide. South African Medical Journal 1982; 61: 349–351
   PubMed Web of Science ®Google Scholar
• Lichtigfeld F. J., Gillman M. A. Advances in understanding alcohol withdrawal states. Postgraduate Medical Journal 1991; 67: 700
   PubMedGoogle Scholar
• Marshall R. J. The pharmacology of mianserin–an update. British Journal Clinical Pharmacology 1983; 15: 263S–268S
   PubMedGoogle Scholar
• McGeer P. L., McGeer E. G. Amino acid neurotransmitters. Basic Neurochemistry, G. J. Siegel, B. W. Agranoff, R. W. Albers, P. B. Molinoff. Raven, New York 1989; 311–332
   Google Scholar
• Moncado S., Palmer R. M. J., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 1991; 43: 109–142
   PubMed Web of Science ®Google Scholar
• Murphy J. M., McBride W. J., Lumeng L., Li T. K. Serotonin and ethanol drinking in the alcohol-preferring (P rat). Clinical Neuropharmacology 1992; 15(suppl 1)301A–302A
   Google Scholar
• Nakao K., Nakai Y., Jingami H., Oki S., Fukata J., Imura H. Substantial rise of plasma Beta-endorphin levels after insulin-induced hypoglycemia in human subjects. Journal of Clinical Endocrinology and Metabolism 1979; 49: 838–841
   PubMed Web of Science ®Google Scholar
• Naranjo C. A., George S. R., Bremner K. E. Novel neuropharmacological treatments of alcohol dependence. Clinical Neuropharmacology 1992; 15(suppl 1)74A–75A
   Google Scholar
• Nutt D. J., Glue P., Wilson S., Coupland N., Lillywhite A. Clinical correlates of benzodiazepine receptor function. Clinical Neuropharmacology 1992; 15(suppl 1)679A–680A
   Google Scholar
• Ojutkangas R. Analgesic nitrous oxide: rapid, safe therapy for addictive withdrawal. Postgraduate Medical Journal 1991; 67: 1027–1028
   PubMed Web of Science ®Google Scholar
• Oreland L., Harrow J., Jossan S. S., Vasar E. Selective damage of locus coeruleus projections modulates CCK receptor characteristics and exploratory behaviour. Clinical Neuropharmacology 1992; 15(suppl 1)289B
   PubMedGoogle Scholar
• Osmanovic S. S., Shefner S. A. GABA-aminobutyric responses in rat locus coeruleus neurons in vitro: a current-clamp and voltage-clamp study. Journal of Physiology 1990; 421: 151–170
   PubMedGoogle Scholar
• Oswald I., Evans J. I., Lewis S. A. Addictive drugs cause suppression of paradoxical sleep with withdrawal rebound. Scientific Basis of Drug Dependence, H. Steinberg. Churchill, London 1969; 243–257
   Google Scholar
• Peachey J. E., Naranjo C. A. The role of drugs in the treatment of alcoholism. Drugs 1984; 27: 171–182
   PubMed Web of Science ®Google Scholar
• Prather P. L., Rezazadeh S. M., Lal H. Mianserin in the treatment of ethanol withdrawal in the rat: prevention of behaviours indicative of anxiety. Psychopharmacological Bulletin 1991; 27: 285–289
   PubMedGoogle Scholar
• Pujol J. F., Keane P., McRae A., Lewis B. B., Renaud B. Biochemical evidence for serotinergic control of the Locus ceruleus. Interactions Between Putative Neurotransmitters in the Brain, S. Garattini, J. F. Pujol, R. Samanin. Raven Press, New York 1978; 401–410
   Google Scholar
• Pycock C. J., Burns S., Morris R. In vitro release of 5-hydroxytryptamine and gamma-amino-butyric acid from rat periaqueductal grey and raphe dorsalis region produced by morphine or an enkephalin analogue. Neuroscience Letter 1981; 22: 213–317
   Google Scholar
• Quock R. M., Muller J. L. Contrasting influences of 5-hydroxytryptamine receptors in nitrous oxide antinociception in mice. Pharmacology Biochemistry & Behaviour 1992; 41: 429–432
   PubMedGoogle Scholar
• Quock R. M., Emmanouil D. E., Vaugh L. K., Proes R. J. Benzodiazepine receptor mediation of behavioural effects of nitrous oxide in mice. Psychopharmacology 1992; 107: 310–314
   PubMed Web of Science ®Google Scholar
• Rasmussen K., Aghajanian G. K. Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT 2 antagonists. Brain Research 1986; 385: 395–400
   PubMedGoogle Scholar
• Redmond D. E., Jnr, Tand Krystal J. H. Multiple mechanisms of withdrawal from opioid drugs. Ann. Rev. Neuroscience 1984; 7: 443–478
   PubMed Web of Science ®Google Scholar
• Redmond D. E., Inr. Studies of the nucleus coeruleus in monkeys and hypotheses for neuro-psychopharmacology. Psychopharmacology: the third generation of progress, H. Y. Meltzer. Raven Press, New York 1987; 967–975
   Google Scholar
• Saffey K., Gillman M. A., Cantrill R. C. Chronic in vivo ethanol administration alters the sensitivity of adenylate cyclase coupling in homogenates of rat brain. Neuroscience Letters 1988; 84: 317–322
   PubMedGoogle Scholar
• Samanin R., Quattroni A., Consolo S., Ladinski H., Algeri S. Biochemical and pharmacological evidence of the interaction of serotonin with other aminergic systems in the brain. Interactions Between Putative Neurotransmitters in the Brain, S. Garattini, J. F. Pujol, R. Samanin. Raven Press, New York 1978; 383–399
   Google Scholar
• Sano H., Suzuli Y., Yazaki R., Tamefusa K., Ohara K., Yokoyama T., Miyasato K., Ohara K. Circadian variation in plasma 5-hydroxyindoleacetic acid level during and after alcohol withdrawal: phase advances in alcoholic patients compared with normal subjects. Acta Psychiatrica Scandinavia 1993; 87: 291–296
   PubMed Web of Science ®Google Scholar
• Sieghart W. Heterogeneity of GABAa receptors. Clinical Neuropharmacology, 15 Suppl 1992; 1: 681A–682A
   Google Scholar
• Sorensen S. C., Mattisson K. Naloxone as an antagonist in severe alcohol intoxication. Lancet 1978; 2: 688–689
   PubMed Web of Science ®Google Scholar
• Stinus L., Cador M., Le Moal M. Interactions between endogenous opioids and dopamine within the nucleus accumbens. Annals New York Academy of Sciences 1992; 654: 254–273
   PubMed Web of Science ®Google Scholar
• Tabakoff B., Hoffman P. L. Interactions of ethanol with opiate receptors: Implications for the mechanism of action of ethanol. Brain Reward Systems and Abuse 1987; 99–107, Ibid.
   Google Scholar
• Tabakoff B., Rabi C. S., Hoffman P. L. Selective effects of sedative/hypnotic drugs on excitatory amino acid receptors in brain. Annals New York Academy of Sciences 1991; 625: 488–495
   PubMedGoogle Scholar
• Ticku M. K., Mhatre M. C. Alcohol modulation of GABAa receptor function and gene expression. Clinical Neuropharmacology 1992; 15(Suppl 1)299A–300A
   Google Scholar
• Tran V. T., Snyder S. H., Major L. F., Hawley R. J. GABA receptors are increased in brains of alcoholics. Annals of Neurology 1981; 9: 289–292
   PubMed Web of Science ®Google Scholar
• Tung C. S., Ugedo L., Grenhoff J., Engberg G., Svensson T. H. Peripheral induction of burst firing in locus coeruleus neurons by nicotine mediated via excitatory amino acids. Synapse 1989; 4: 313–318
   PubMedGoogle Scholar
• Vargas M. A., Bissett G., Owens M. J., Ehlers C. L., Nemeroff C. B. Effects of chronic ethanol and benzodiazepine treatment and withdrawal on corticotropin-releasing factor neural systems. Annals of New York Academy of Sciences 1992; 654: 145–152
   PubMedGoogle Scholar
• Victor M. The role of hypomagnesemia and respiratory alkalosis in the genesis of alcoholwithdrawal symptoms. Annals of New York Academy of Sciences 1973; 215: 235–248
   PubMed Web of Science ®Google Scholar
• West R. E., Miller R. J. Opiates, second messengers and cell response. British Medical Bulletin 1983; 39: 53–58
   PubMedGoogle Scholar
• Willer J. C., Ernst M. Diazepam reduces stress-induced analgesia in humans. Brain Research 1986; 362: 398–402
   PubMedGoogle Scholar
• Wood P. L. Pharmacology of the second messenger, cyclic guanosine 3,5-monophosphate, in the cerebellum. Pharmacological Reviews 1991; 43: 2–25
   Google Scholar
• Wortis J. In memoriam. Manfred Sakel M.D. 1900–1957. American Journal of Psychiatry 1958; 115: 287–288
   Google Scholar
• Wortis J., Bowman K. M., Goldfarb W. The use of insulin in the treatment of alcoholism. Medical Clinics of North America 1940; 24: 671–681
   Google Scholar
• Zukin S. R., Javett D. C. The brain NMDA receptor, psychotomimetic drug effects and schizophrenia. Review of Psychiatry vol 10, A. Tasmin, S. M. Goldfinger. American Psychiatric Press, Washington 1991; 480–496
   Google Scholar